Cargando…
Systemic Therapy for Metastatic Triple Negative Breast Cancer: Current Treatments and Future Directions
SIMPLE SUMMARY: Triple negative breast cancer, a subtype of breast cancer that does not respond to hormone therapy, is typically more aggressive and affects younger patients. Treatment has traditionally been limited to chemotherapy, with poor survival for patients with advanced disease. More recentl...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417818/ https://www.ncbi.nlm.nih.gov/pubmed/37568617 http://dx.doi.org/10.3390/cancers15153801 |